AbadieR.The professional guinea pig: big pharma and the risky world of human subjects. Durham, NC: Duke University Press, 2010.
3.
ZvonarevaOPimenovIKutishenkoN, et al. Informal professionalization of healthy participants in phase I clinical trials in Russia. Clin Trials, this issue.
4.
AbbottA.The system of professions: an essay on the division of expert labor. Chicago, IL: University of Chicago Press, 1988.
5.
LarsonMS.The rise of professionalism: a sociological analysis. Berkeley, CA: University of California Press, 1979.
6.
BrownAD.Identities and identity work in organizations. Int J Manage Rev2015; 17: 20–40.
7.
EdelbluteHBFisherJA.Using “clinical trial diaries” to track patterns of participation for serial healthy volunteers in U.S. phase I studies. J Empir Res Hum Res Ethics2015; 10(1): 65–75.
8.
FisherJAMcManusLCottinghamMD, et al. Healthy volunteers’ perceptions of risk in US Phase I clinical trials: a mixed-methods study. PLoS Med2018; 15(11): e1002698.
9.
CottinghamMDFisherJA.Risk and emotion among healthy volunteers in clinical trials. Soc Psychol Q2016; 79(3): 222–242.
10.
WilliamsQFisherJA.Captive to the clinic: phase I clinical trials as temporal total institutions. Sociol Inq2018; 88(4): 724–748.
11.
MonahanTFisherJA.“I’m Still a Hustler”: entrepreneurial responses to precarity by participants in phase I clinical trials. Econ Soc2015; 44(4): 545–566.
12.
McManusLFisherJA.To report or not to report: exploring healthy volunteers’ rationales for disclosing adverse events in phase I drug trials. AJOB Empir Bioeth2018; 9: 82–90.
13.
DresserR.Subversive subjects: rule-breaking and deception in clinical trials. J Law Med Ethics2013; 41(4): 829–840.
14.
ResnikDBMcCannDJ.Deception by research participants. N Engl J Med2015; 373: 1192–1193.
15.
DevineEGWatersMEPutnamM, et al. Concealment and fabrication by experienced research subjects. Clin Trials2013; 10(6): 935–948.
16.
DickertNW.Concealment and fabrication: the hidden price of payment for research participation. Clin Trials2013; 10(6): 840–841.